Ammar Yousif is an Oncology physician affiliated with Comprehensive Cancer Centers of Nevada. OpenAlex indexes 20 publications with 323 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9280 W Sunset Rd Ste 100
Las Vegas, NV 891484861
Telephone
702-952-1251Provider last certified this registry record 12 Nov 2024.
Industry payments
90 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202533 payments
- Daiichi Sankyo Inc.Program year202537 payments
- Merck Sharp & Dohme LLCProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
59.2%Corticosteroid59.2%Dexamethasone sodium phosphate99%Dexamethasone2%Part D + Part B≥12 patientsCancer & immunology
15.8%Aromatase Inhibitor6.4%Letrozole76%Anastrozole24%Part D≥56 patientsKinase inhibitor2.7%Brukinsa23%Calquence17%Kisqali17%Imbruvica16%Verzenio14%Alecensa13%Part D<11 patients+ 7 more classes in this area
Nervous system
7.3%Opioid Agonist4.1%Oxycodone-Acetaminophen51%Morphine Sulfate Er25%Oxycodone Hcl15%Tramadol Hcl9%Part D<11 patientsPhenothiazine1.1%Prochlorperazine Maleate100%Part D≥13 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Intraocular metastasis from an anal squamous cell carcinoma: a case report
Journal of Gastrointestinal Oncology
2025 - Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients
Infection Control and Hospital Epidemiology
2018 - Relationship between dental loss and health outcomes among hospitalized patients with and without diabetes
Journal of Investigative Medicine
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Nicholas Vogelzang, MD
Comprehensive Cancer Centers of Nevada
Fadi Braiteh, MD
Comprehensive Cancer Centers of Nevada
Oscar Goodman, MD
Comprehensive Cancer Centers of Nevada
Raul Meoz, MD
Comprehensive Cancer Centers of Nevada
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”